Operator Good day, and welcome to the Altria Group 2024 fourth quarter and full year earnings conference call. [Operator ...

A recent study from researchers at Wake Forest University School of Medicine and Rutgers University shows a high rate of ...

The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco ...

A Sheffield off-licence has had its licence revoked because it has been caught employing illegal workers, selling illicit tobacco products and serving under-age children with tobacco and alcohol.

Compared to its American brethren, Altria Group, which had an 8.6% cigarette volume decline last quarter, Philip Morris ...

Restricting the sale of oral nicotine pouches to adults-only tobacco stores, increasing the minimum price of cigars to be ...

UBS upgraded British American Tobacco (BTI) to Buy from Neutral with a price target of 3,900 GBp, up from 3,000 GBp. The firm views the stock’s ...

ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...

Following an extensive scientific review, the US Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products.

The FDA has given marketing authorization to Zyn nicotine pouches. That doesn't necessarily mean they're safe to use, ...

Altria Group, Inc. MO, well-known for its presence in the tobacco and vaping industries, has witnessed a 3.9% decline in its ...

When you buy through links on our articles ... The FDA in mid-January endorsed the health benefits of nicotine pouches like ...